NOVEL MUTATIONS OF THE G6PC GENE IN MALAYSIANS WITH GLYCOGEN STORAGE DISEASE 1a (GSD1a)

Q3 Multidisciplinary Malaysian journal of science Pub Date : 2021-02-28 DOI:10.22452/MJS.VOL40NO1.3
Amirah Assyiqqin Abd Rahman, Ili Syazwana Abdullah, Teh Ser Huy, F. D. Khaidizar, S. Yap, K. W. Teik, Ngu Lock Hock, Chew Hui Bein, Ong Pei Tee, Z. Mohamed
{"title":"NOVEL MUTATIONS OF THE G6PC GENE IN MALAYSIANS WITH GLYCOGEN STORAGE DISEASE 1a (GSD1a)","authors":"Amirah Assyiqqin Abd Rahman, Ili Syazwana Abdullah, Teh Ser Huy, F. D. Khaidizar, S. Yap, K. W. Teik, Ngu Lock Hock, Chew Hui Bein, Ong Pei Tee, Z. Mohamed","doi":"10.22452/MJS.VOL40NO1.3","DOIUrl":null,"url":null,"abstract":"Abstract \nGlycogen Storage Disease 1a is a rare autosomal recessive disorder caused by mutations in the glucose-6-phosphatase gene (G6PC) encoding glucose-6-phosphatase (G6Pase), a key enzyme for the maintenance of glucose homeostasis. Deficiency of G6Pase underlies this disease associated with life-threatening hypoglycemia and growth retardation. To date, more than 110 mutations have be found worldwide.The aims of this study are to identify the mutations in G6PC gene in Malaysian GSD1a patients using standard molecular genetics methods and to determine the pathogenicity level of the novel mutations. We performed mutation screening for 21 GSD1a unrelated patients (Malay n=14; Chinese n=7) using Polymerase Chain Reaction (PCR) and DNA sequencing. Genomic DNA was extracted from patients’ peripheral blood and all five G6PC exons were amplified using specific primers. Nine mutations were found, in which five mutations have been previously reported and four are potentially novel mutations (H52L, K76X, P113S and A346P). To obtain further evidence on the potential pathogenicity of the novel mutations, restriction enzyme assay and TaqMan genotyping assay were designed to investigate its allele frequency in a panel of healthy individuals that serves as the control population samples (n=50 Malays, n=50 Chinese, n=50 Indians). Restriction enzymes MseI and MboI were used to assay the K76X and P113S mutations respectively. For the other two mutations (H52L and A346P), TaqMan genotyping assays was employed due to inavailability of a suitable restriction enzyme to distinguish between the normal and mutant sequences. Results obtained from both the restriction enzymes assays and the TaqMan assays showed that no mutant allele could be found in all 150 healthy individuals (300 alleles). In conclusion, four yet unreported mutations have been found in the Malaysian population, and these mutations are potentially novel pathogenic mutations. These finding provide support that the mutations spectrum of G6PC gene in Malaysia is heterogeneous, at least among the Chinese and Malay populations. \nKEY WORDS: Glycogen storage disease type 1a (GSD1a); glucose-6-phosphatase enzyme (G6Pase); Glucose-6-Phosphate catalytic subunit (G6PC).","PeriodicalId":18094,"journal":{"name":"Malaysian journal of science","volume":"40 1","pages":"34-45"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Malaysian journal of science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22452/MJS.VOL40NO1.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Multidisciplinary","Score":null,"Total":0}
引用次数: 1

Abstract

Abstract Glycogen Storage Disease 1a is a rare autosomal recessive disorder caused by mutations in the glucose-6-phosphatase gene (G6PC) encoding glucose-6-phosphatase (G6Pase), a key enzyme for the maintenance of glucose homeostasis. Deficiency of G6Pase underlies this disease associated with life-threatening hypoglycemia and growth retardation. To date, more than 110 mutations have be found worldwide.The aims of this study are to identify the mutations in G6PC gene in Malaysian GSD1a patients using standard molecular genetics methods and to determine the pathogenicity level of the novel mutations. We performed mutation screening for 21 GSD1a unrelated patients (Malay n=14; Chinese n=7) using Polymerase Chain Reaction (PCR) and DNA sequencing. Genomic DNA was extracted from patients’ peripheral blood and all five G6PC exons were amplified using specific primers. Nine mutations were found, in which five mutations have been previously reported and four are potentially novel mutations (H52L, K76X, P113S and A346P). To obtain further evidence on the potential pathogenicity of the novel mutations, restriction enzyme assay and TaqMan genotyping assay were designed to investigate its allele frequency in a panel of healthy individuals that serves as the control population samples (n=50 Malays, n=50 Chinese, n=50 Indians). Restriction enzymes MseI and MboI were used to assay the K76X and P113S mutations respectively. For the other two mutations (H52L and A346P), TaqMan genotyping assays was employed due to inavailability of a suitable restriction enzyme to distinguish between the normal and mutant sequences. Results obtained from both the restriction enzymes assays and the TaqMan assays showed that no mutant allele could be found in all 150 healthy individuals (300 alleles). In conclusion, four yet unreported mutations have been found in the Malaysian population, and these mutations are potentially novel pathogenic mutations. These finding provide support that the mutations spectrum of G6PC gene in Malaysia is heterogeneous, at least among the Chinese and Malay populations. KEY WORDS: Glycogen storage disease type 1a (GSD1a); glucose-6-phosphatase enzyme (G6Pase); Glucose-6-Phosphate catalytic subunit (G6PC).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
马来西亚糖原储存病1a (GSD1a)患者G6PC基因的新突变
摘要糖原贮积病1a是一种罕见的常染色体隐性遗传疾病,由编码葡萄糖-6-磷酸酶(G6Pase)的葡萄糖-6-磷酸酶基因(G6PC)突变引起,葡萄糖-6-磷酸酶是维持葡萄糖稳态的关键酶。G6Pase缺乏是这种与危及生命的低血糖和生长迟缓相关的疾病的基础。迄今为止,全球已发现110多个突变。本研究的目的是使用标准分子遗传学方法鉴定马来西亚GSD1a患者G6PC基因的突变,并确定新突变的致病性水平。我们使用聚合酶链式反应(PCR)和DNA测序对21名GSD1a无关患者(马来人n=14;中国人n=7)进行了突变筛查。从患者外周血中提取基因组DNA,并使用特异性引物扩增所有5个G6PC外显子。发现了9个突变,其中5个突变先前已报道,4个是潜在的新突变(H52L、K76X、P113S和A346P)。为了获得关于新突变潜在致病性的进一步证据,设计了限制性内切酶分析和TaqMan基因分型分析,以研究其在一组健康个体中的等位基因频率,这些健康个体作为对照群体样本(n=50马来人,n=50中国人,n=50Indians)。限制性内切酶MseI和MboI分别用于检测K76X和P113S突变。对于其他两个突变(H52L和A346P),由于没有合适的限制性内切酶来区分正常序列和突变序列,因此采用了TaqMan基因分型分析。从限制性内切酶测定和TaqMan测定中获得的结果表明,在所有150个健康个体(300个等位基因)中均未发现突变等位基因。总之,在马来西亚人群中发现了四种尚未报告的突变,这些突变可能是新的致病突变。这些发现支持了马来西亚G6PC基因的突变谱是异质性的,至少在中国和马来人群中是如此。关键词:糖原贮积病1a型(GSD1a);葡萄糖-6-磷酸酶(G6Pase);葡萄糖-6-磷酸催化亚基(G6PC)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Malaysian journal of science
Malaysian journal of science Multidisciplinary-Multidisciplinary
CiteScore
1.10
自引率
0.00%
发文量
36
期刊介绍: Information not localized
期刊最新文献
EVALUATION OF Zr, Ni-Cr, And Au-Ag APPLIED MATERIALS USING FEM ON PROSTHETIC CROWNS THE BENEFITS OF FERMENTED GOAT’S MILK WHEY MASK WITH HONEY AND RED FRUIT (Pandanus conoideus) AS ANTIOXIDANT AGENT THE EFFECTIVENESS OF APPLICATIONS OF BETEL (Piper Betel Linn.) LEAF EXTRACT AND BACTERIOCIN FOR TEAT DIPPING DURING MILKING HANDLING IN INDONESIAN DAIRY FARMING SPECTRAL AND STRUCTURAL ANALYSIS FOR SODIUM SILICATE-BASED AEROGEL VIA NORMAL DRYING PRESSURE SLOW AND FAST SUBSYSTEMS FOR COMPLEX UNCOMPETITIVE INHIBITOR MECHANISMS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1